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The purpose of this pilot study was to compare walking speed, an important component
of gait, in the laboratory and daily life, in young individuals with cerebral palsy (CP) and
with typical development (TD), and to quantify to what extent gait observed in clinical
settings compares to gait in real life. Fifteen children, adolescents and young adults
with CP (6 GMFCS I, 2 GMFCS II, and 7 GMFCS III) and 14 with TD were included.
They wore 4 synchronized inertial sensors on their shanks and thighs while walking
at their spontaneous self-selected speed in the laboratory, and then during 2 week-
days and 1 weekend day in their daily environment. Walking speed was computed from
shank angular velocity signals using a validated algorithm. The median of the speed
distributions in the laboratory and daily life were compared at the group and individual
levels using Wilcoxon tests and Spearman’s correlation coefficients. The corresponding
percentile of daily life speed equivalent to the speed in the laboratory was computed and
observed at the group level. Daily-life walking speed was significantly lower compared
to the laboratory for the CP group (0.91 [0.58–1.23] m/s vs 1.07 [0.73–1.28] m/s,
p = 0.015), but not for TD (1.29 [1.24–1.40] m/s vs 1.29 [1.20–1.40] m/s, p = 0.715).
Median speeds correlated highly in CP (p < 0.001, rho = 0.89), but not in TD. In
children with CP, 60% of the daily life walking activity was at a slower speed than in-
laboratory (corresponding percentile = 60). On the contrary, almost 60% of the daily life
activity of TD was at a faster speed than in-laboratory (corresponding percentile = 42.5).
Nevertheless, highly heterogeneous behaviors were observed within both populations
and within subgroups of GMFCS level. At the group level, children with CP tend to under-
perform during natural walking as compared to walking in a clinical environment. The
heterogeneous behaviors at the individual level indicate that real-life gait performance
cannot be directly inferred from in-laboratory capacity. This emphasizes the importance
of completing clinical gait analysis with data from daily life, to better understand the
overall function of children with CP.
Keywords: cerebral palsy, typical development, capacity, performance, inertial sensors, walking speed
Abbreviations: CP, cerebral palsy; F, female; GMFCS, Gross Motor Function Classification System; M, male; TD, typical
development.
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INTRODUCTION
The World Health Organization (WHO) has emphasized the
need to consider both capacity, defined as what a person can
do in a standardized environment, and performance, defined
as what a person does in his/her habitual environment, to
describe a person’s activity. These descriptors account for
the role of impairments in body functions as well as the
impact of the environment and other personal factors on
activity and participation (World Health Organization, 2002).
Since the usual environment includes the overall societal
context, performance considers external and personal factors,
unlike capacity, which focuses on functional abilities. Walking
capacity and performance can thus be interpreted as walking
in clinical (laboratory) and daily life settings, respectively,
(Bjornson, 2019).
In children with cerebral palsy (CP), gait capacity assessments
are a mainstay of clinical evaluation (Gerber et al., 2019).
These children, who present lifelong motor disabilities (O’Shea,
2008), are regularly assessed in clinical settings through diverse
functional tests, such as the Gross Motor Function Measure
(GMFM) (Alotaibi et al., 2014) and the 6-Min Walk Test
(Enright, 2003), or through an exhaustive assessment of gait
deviations using 3D clinical gait analysis (Armand et al., 2016;
Carcreff et al., 2016). This data on gait capacity is used to
identify, quantify and understand the motor disorders, and serves
as a support for the management of gait deviations (Armand
et al., 2016). However, walking under the supervision of the
clinician in a laboratory may not always be representative of
usual walking (Gosselin et al., 2018). The patient’s capacity is
usually overestimated as he/she shows the best of him/herself to
please the care providers (Toosizadeh et al., 2015), a phenomenon
often referred to as the ’Hawthorne effect’ (Berthelot et al., 2011).
Additional information about the patient’s unsupervised walking
(i.e., daily life-based gait performance), as a complement to
laboratory-based assessments, could improve the understanding
of the patient’s overall gait difficulties, enhancing clinical care
(Young et al., 1996; Bjornson et al., 2013; Warmerdam et al.,
2019). It is meaningful for treatment objectives to determine
whether the effect of a treatment, observed in clinical settings
by improvements in capacity, generalizes into the patient’s daily
life by improving performance. Recently Halma et al. (2020)
have demonstrated that improvements in motor capacity are
largely not accompanied by changes in motor performance in
ambulatory children with CP within the context of intensive
therapy, and have emphasized the need to include interventions
specifically aimed at improving motor performance into
treatment programs. In addition, by providing a high amount of
quantitative data about the patient’s habitual gait and confronting
it with clinic-based observations it could help to determine
the level of confidence with which clinicians might predict gait
performance based on laboratory-based assessments. The other
way around, patients might improve their daily functioning by
simply adapting the environment (World Health Organization,
2002), in absence of any change in capacity. Thus, if proven to be
efficient (i.e., using objective performance measurement tools),
clinicians might focus on adapting the environment and working
on personal factors (e.g., with self-efficacy training) especially
when capacity plateaus despite intensive training.
In children with CP, gait performance is mostly assessed by
self- or proxy-report questionnaires which are inherently biased
by subjectivity and misrepresentation (Capio et al., 2010). Since
the advent of new assessment tools like accelerometer-based
pedometers, actimeters or, more generally, inertial measurement
units (IMU) based activity monitors, objective data can be
collected from a patient’s daily activity, and direct comparisons
with data measured in the laboratory can be performed.
Gait capacity and performance assessed by questionnaires are
positively associated in children with CP (Van Eck et al., 2009),
capacity exceeding performance (Young et al., 1996). However,
this relationship is not constant in time and depends on the
level of impairment [classified by the Gross Motor Function
Classification System- GMFCS (Palisano et al., 1997; Ho et al.,
2017]. Indeed, Van Gorp et al. (2018) have recently shown
that performance keeps developing after the ceiling of capacity
is reached. Studies using objective performance data have
highlighted weak correlations of laboratory-based spatiotemporal
and kinematic parameters with daily ambulatory activities of
children with CP (Mitchell et al., 2015; Wilson et al., 2015; Guinet
and Desailly, 2017; Nicholson et al., 2018; Wittry et al., 2018).
Although the comparisons were based on dissimilar metrics (i.e.,
Gait Deviation Index (Schwartz and Rozumalski, 2008) versus
step count per day, for instance), all these findings seem to
indicate that gait performance cannot be predicted directly from
gait capacity (Guinet and Desailly, 2017). On the other hand,
we have recently demonstrated that gait in the laboratory was
highly correlated with gait in daily life while comparing several
identical metrics, including rhythm, pace, amplitude, stability,
coordination, smoothness, variability and asymmetry metrics in
children with CP (Carcreff et al., 2020). This study focused only
on walking bouts in the real-world environment that approached
those in the laboratory by their length and number of steps,
but did not include the wide variety of bouts that take place
during a usual day.
Walking speed is referred to as the sixth vital sign (Fritz
and Lusardi, 2009) since it is a powerful indicator of mobility
efficiency (Bjornson and Lennon, 2017; Van Ancum et al., 2019).
This gait parameter constitutes the most reported outcome
measure of interventions whose aim is to improve gait function
(Bjornson and Lennon, 2017). It is an easy-to-administer
objective and valid measure of walking activity that has been
linked to functional ability and quality of life in children with CP
(Moreau et al., 2016). It can reliably be estimated using IMUs, by
direct integration, biomechanical modeling or machine learning
methods (Yang and Li, 2012). We have recently demonstrated
the satisfactory accuracy and reliability of speed estimation
in children with CP with low to moderate levels of motor
disability (GMFCS levels I to III), using a configuration of
sensors on the shanks and thighs (Carcreff et al., 2018; Gerber
et al., 2019). Recent studies have found that clinic-based speed
corresponded to the highest speeds measured in daily conditions
in community-dwelling older adults (Takayanagi et al., 2019;
Van Ancum et al., 2019), in patients with Parkinson’s disease
(Toosizadeh et al., 2015; Del Din et al., 2016a) and patients
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with multiple sclerosis (Supratak et al., 2018). This has not
been explored in CP.
The aim of this pilot study was to compare the walking
speed of youngsters with CP in the laboratory and in daily
life, by employing our previously validated sensor configuration
(Carcreff et al., 2018; Gerber et al., 2019) and maximizing the
number of walking bouts from real life included into our analyses
to reflect daily performance.
Analyses were also performed in healthy controls with typical
development (TD) since daily-life assessments of gait function are
novel in this population with a need for reference data in order
to draw potential conclusions (Del Din et al., 2016b). Analyses
were performed at the group level, and at the individual level, to
account for the heterogeneity of the CP population.
Three specific research questions were formulated to allow this
comparison: (1) Is spontaneous walking speed in the laboratory
different from daily life?; (2) Is there an association between
speed in the laboratory and in daily life?; and (3) How much
does walking speed in the laboratory represent speed in daily life?
Our hypotheses, based on the literature, were that: (1) walking
speed is different in daily life and in clinical settings, (2) there
is a moderate correlation between speeds estimated in these
two contexts [as previously demonstrated (Mitchell et al., 2015;
Wilson et al., 2015; Guinet and Desailly, 2017; Nicholson et al.,
2018; Wittry et al., 2018)] and, (3) walking speed in the laboratory
represents the highest speed in daily life for children with CP (as
demonstrated in other populations).
MATERIALS AND METHODS
Recruitment
Children, adolescents and young adults with CP (often referred
to ‘children’ in the rest of the manuscript) were recruited for
this pilot study from the pediatric orthopedic unit of Geneva
University Hospitals using the following inclusion criteria: aged
between 8 and 20 years, diagnosis of CP, ability to walk
in the community with or without mechanical walking aids
(e.g., crutches, tripods or walker), i.e., with a GMFCS level
(Palisano et al., 1997) between I and III. A group of children,
adolescents and young adults with TD, homogeneous in age
and sex with the CP group, were recruited among collaborators’
or patients’ acquaintances. Individuals of both groups were
excluded if they had additional impairments that limited their
participation in the measurements (mental age <8 years, severe
visual impairment, attention deficit and/or other significant
behavioral issues). Written informed consent was obtained from
participants ≥14 years old or their legal guardian if younger,
and the protocol was approved by and carried out in accordance
with the hospital’s institutional ethical committee (Cantonal
Commission for Research Ethics of Geneva – CCER-15-176).
Protocol
A trained investigator measured anthropometric data (shank and
thigh lengths) and lower limb muscle strength. The GMFM (66-
item version) (Alotaibi et al., 2014) was assessed for the children
with CP by a trained evaluator to score their functional capacity
(from 0 to 100, 100 being the highest capacity).
Children were equipped with wearable inertial sensors and
reflective markers (optoelectronic system). They were asked to
walk barefoot at a natural self-selected pace (with the instruction
to walk “as usual, as you walk in the street”), back and forth
on a 10-meter walkway within the gait laboratory, following a
standard protocol of clinical gait analysis (Baker, 2013). A total
of 4 to 10 trials were recorded for each participant, depending on
their capacity and fatigue.
Next, the participants were asked to wear the sensors in
their daily life, for a minimum of 10 waking hours per day,
during 3 consecutive days including 2 week-days (school days)
and 1 weekend day. The sensors were placed at the beginning
and recharged at the end of each day of measurement by a
parent, a caregiver or the participant him/herself. Previously, they
received a practical training by the investigator on how to handle
the sensors, i.e., turning on, fixing on body segments, turning
off, charging, etc. A guide was also given to support them at
home. The participants were asked to complete a diary reporting
their physical activities and the eventual issues encountered
with the sensors.
Wearable Sensors
Four synchronized IMU-based devices (Physilog4 R©, Gait Up,
Switzerland) were used, one on each shank and thigh (Figure 1),
since this configuration was demonstrated to be the most
adequate lower-limb configuration to assess the walking speed
in youths with CP throughout GMFCS level I to III (Carcreff
et al., 2018). Each device comprised a triaxial accelerometer
(range ± 16 g) and gyroscope (range ± 1000◦/s). The sampling
frequency was set at 100 Hz. During the measures in the
laboratory, the devices were safely fixed with a hypoallergenic
adhesive film (Opsite Flexigrid, Smith & Nephew Medical,
United Kingdom). During the daily life measures, the devices
were fixed with a hypoallergenic double-sided hydrogel sticky
(PAL stickies, PAL Technologies Ltd., United Kingdom) and
protected from falling with a handmade Elastane sleeve, or under
tight pants and socks.
Optoelectronic System
The IMUs were synchronized with a twelve-camera
optoelectronic system (Oqus7+, Qualisys Göteborg, Sweden)
according to the protocol described in a previous paper whose
goal was to compare gait parameter outputs from the clinical
silver standard and the wearable system (Carcreff et al., 2018).
In the present study, the optoelectronic system was only used to
automatically crop continuous IMUs’ data into several straight
gait trials (to discard turns and standing periods).
Data Processing
Figure 2 details the data processing steps.
In-Laboratory Measures
The 3D continuous angular velocity data was automatically
cropped into several straight walking episodes (corresponding
to each back and forth trial on the walkway in the laboratory,
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FIGURE 1 | Sensor placement. Four sensors were placed on the participant’s
lower limbs. The orientation of the sensors’ axes (colored arrows) was not
imposed since the sensor-to-segment alignment was performed in
post-processing using the PCA approach described in the section “Data
Analysis.”
excluding the turns) by using the optoelectronic system’s start
and stop of each trial. The pitch angular velocity (around the
medio-lateral axis) was extracted using a principal component
analysis (PCA), as the principal axis of movement during
gait was assumed to correspond to the movement around the
medio-lateral axis (Mcgrath et al., 2018). Gait events [heel
strikes (HS), toe offs (TO)] were identified on the pitch
angular velocity of the shanks as described by Aminian et al.
(2002); Salarian et al. (2004). Succession of right and left
steps were checked based on the times of HS and TO of
each side. Shanks and thighs angles for each stride were
computed by trapezoidal integration between HS and TO,
and between TO and HS for each walking trial with good
succession of right and left steps. Walking speed was computed
(cf. “Walking speed computation” section) for each gait cycle
and for each trial.
Daily Life Measures
Continuous recordings were cropped so that all files of the same
day had the same time of recording (i.e., the minimal time shared
between the 4 sensors). Walking episodes were detected using
the axis of angular velocity with the highest amplitude of both
shanks based on the peak detection method described by Salarian
et al. (2004) personalized at the individuals level as described
in a previous paper (Carcreff et al., 2019b). The 3D signal of
the longest detected walking bout was used to determine the
PCA coefficients to ensure selecting a steady-state walking bout.
Then, the axis alignment was performed on the entire signal
to extract the pitch angular velocity. Drift and noise on the
signal were removed using an Infinite Impulse Response (IIR)
high pass filter (Salarian et al., 2004). Only the episodes with
a minimum of 10 steps were selected for further analysis. This
threshold was chosen based on inputs from clinicians and was
used in previous studies (Prajapati et al., 2011; Brodie et al.,
2016). A minimum of 10 steps also approximately corresponded
to the number of steps per 10 m trials in the laboratory while it
would assure to have a continuous walking bout without break,
less affected by the context such as short walking in a room,
fidgeting, or obstacle avoidance. HS and TO were identified, the
succession of right and left steps were checked, and the shank
and thigh angles were computed for each stride as described
in the “In-laboratory measures” section. Atypical values of gait
cycle potentially related to environmental contexts (e.g., turning,
obstacle avoidance) were excluded. Criteria for exclusion were
defined by taking the minimum and maximum values of each
parameter from previous in-laboratory assessments at various
speeds, in both the CP and the TD groups, i.e., a gait cycle
time less than 0.6 s and more than 3.5 s, or a shank sagittal
ranges of motion less than 25◦ and more than 95◦ (Carcreff
et al., 2019b, 2020). This procedure was necessary to exclude the
false positive detected cycles. Stride length and walking speed
were estimated for each remaining gait cycles of the included
walking episode.
Walking Speed Computation
For both sources of measurements (in-laboratory and daily-
life), walking speed was computed from the ratio between
the stride length and the stride time. The stride time is
the time difference between two successive foot-strikes. The
stride length is computed from the pitch angular velocity
of the shanks and thighs, based on the double pendulum
model (Aminian et al., 2002; Salarian et al., 2004). This
model uses the thigh and shank lengths and their rotation
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FIGURE 2 | Flow chart of data processing steps. In green are represented the steps specific to daily life measures. Abbreviations: ω1D: 1-axis angular velocity; ω3D:
3-axis angular velocity; ωz: pitch angular velocity; PCA: Principal Component Analysis; WB: Walking bout; IIR: infinite impulse response; nb steps: number of steps;
HS: Heel strike; TO: Toe off; HSR: Heel strike right; HSL: Heel strike left; TOR: Toe off right; TOL: Toe off left; NaN: Not A Number; GCT: Gait Cycle Time; Sh,Th:
Shank and thigh; SL: Stride length; WS: Walking speed.
in the sagittal plane (computed by numerical integration
of pitch angular velocities) between foot-strike and foot-off,
to compute the stride length, as illustrated on Figure 3.
The accuracy of the system for walking speed estimation is
0.07 m/s, in children and adolescents with and without CP
regardless of the level of impairment (Carcreff et al., 2018).
Walking speed was thus reported by stride (including right
and left steps).
Data Analysis
GMFM scores, muscle strength information and use of walking
aids were used as descriptive clinical features.
Description of the Ambulatory Contexts
The ambulatory activities (number of steps in-laboratory, total
number of steps per day in daily life, median and maximal
number of consecutive steps) were described for each group and
each day type (week-day or weekend day) in order to set the
context of the measurements. Cumulative Distribution Function
(CDF) plots were used to visualize the speed distribution
in-laboratory (CDFLab) and during each day of daily life
(CDFDL) on the same figure, in order to make direct visual
comparisons between the distributions. CDF plots were preferred
to histograms for better readability in the superposition of
the distributions.
Comparisons Between Laboratory and Daily Life
Speeds
The results obtained from the 3 days recorded data were
gathered in order to provide a more accurate representation
of gait throughout the week. A single daily life distribution
representing both week-days and weekend days was thus
obtained. Outlier values (∈[Q1-1.5∗IQR:Q3+1.5∗IQR] with
Q1:1st quartile; Q3:3rd quartile and IQR: interquartile range)
were excluded from this single distribution. The level of
significance for the following statistical tests was set at p < 0.05.
Difference Between Speed in Laboratory and Speed
in Daily Life
Median of speed distributions in laboratory and in daily life were
compared for each group (group level) and subgroups of GMFCS
using the nonparametric paired Wilcoxon tests (indicated for
small sample size). The speed distribution (all gait cycles) in
the laboratory was also compared to the daily life distribution
for each participant (individual level) using unpaired Wilcoxon
tests. Effect size was computed by dividing the Wilcoxon test
statistic by the square root of the number of observations, as
suggested by Pallant (2013). Results were described in absolute
speed to guarantee better readability (by keeping meaningful
units, i.e., m/s). Results regarding normalized speed [/
√
(g∗leg
length) (Hof, 1996)] were also computed to ensure consistency
of the conclusions.
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FIGURE 3 | The double pendulum model. The double pendulum model estimates the stride length from the distances d1, d2, d3. d1 and d3 are estimated from α,
which is obtained from the angular velocity signal of the thigh (during the swing pendulum) and the segments length (L1, L2); d2 is estimated from β, which is
obtained from the angular velocity signal of the shank (during the stance pendulum) and the segments length (L1, L2). For more information, refer to Aminian et al.
(2002).
Association Between Speed in Laboratory and Speed
in Daily Life
The correlation between median speed in the laboratory and
median speed in daily life was assessed by using Spearman’s
rank correlation coefficient (rho). Altman’s guidelines were
used to interpret the correlation as: poor if rho < 0.2; fair
if 0.21 < rho < 0.40; moderate if 0.41 < rho < 0.60;
good if 0.61 < rho < 0.80; and very good if rho > 0.81
(Altman and Altman, 1999).
Speed in the Laboratory Representative of Speed in
Daily Life
The percentile from the daily life distribution that corresponded
to the median speed in laboratory was calculated, according to
the method of Van Ancum et al. (2019). As an example, if the
median speed in daily life equals the median speed in laboratory,
the corresponding percentile would be 50.
RESULTS
Description of the Study Population and
the Ambulatory Contexts
Fifteen youths with CP and 14 with TD were included in this
study. The details about the CP population are provided in
Table 1 and the characteristics of each group are presented in
Table 2.
For participants with CP, the dominant clinical pattern
was spastic diplegia (n = 12). Therefore, the majority was
affected on both sides, and half of the patients needed a
walking aid for outdoor walking. The GMFM scores ranged
between 37.4 and 100. One child with CP – GMFCS III
did not walk enough during 2 days since she largely used
her wheelchair to move, so no walking episode with more
than 10 steps was detected, hence only 1 day (week-day)
was considered for this participant. One adolescent with TD
forgot to wear the sensors during the third day (weekend
day). Two children with CP (GMFCS I and III) did not
follow the instruction to wear the sensors on a weekend
day, thus 3 week-days were assessed for them. Table 2
gives an overview of the detected ambulatory activities in
each group in laboratory and daily life. In general, children
with CP took fewer steps than children with TD. The
number of steps taken, as well as the time spent walking
during weekend days was lower compared with the week-
days for both groups. Especially, the median number of
consecutive steps during weekend days represented only 8
and 3% of the median number of consecutive steps during
week-days in children with CP and TD, respectively. One
child with TD took more than 10’000 steps and this during
a week-day.
The distributions of in-laboratory and daily-life speeds
were visualized as superimposed CDF plots, and 6 examples
are reported in Figure 4. We observed heterogeneous
behaviors regarding the difference between in-laboratory
and daily-life distributions. The right shift of the CDFLab
with respect to the CDFDL indicates that some children
walked mainly at lower speeds in daily life than in laboratory
Frontiers in Bioengineering and Biotechnology | www.frontiersin.org 6 July 2020 | Volume 8 | Article 812
fbioe-08-00812 July 10, 2020 Time: 18:41 # 7
Carcreff et al. Walking Speed in Cerebral Palsy
TABLE 1 | Description of the CP population.
Age Sex GMFCS GMFM Topography More affected side1 Walking aid in laboratory Walking aid in DL
13.7 F I 86.5 Uni L
12.3 F I 89.7 Uni R
15.6 M I 88.0 Uni R
20.1 M I 88.0 Bi R
13.2 M I 100.0 Bi L
12.3 F I 100.0 Bi R
12.8 M II 78.3 Bi L
10.3 F II 65.6 Bi R wheelchair for long distances
9.3 F II 67.4 Bi L
14 F III 68.5 Bi L walker
15.8 F III 54.1 Bi R walker walker or wheelchair
8.3 M III 57.9 Bi R walker walker
11.3 M III 54.9 Bi L walker walker
11.6 F III 63.6 Bi L crutches crutches or wheelchair
17.5 F III 37.4 Bi R walker walker
1: based on lower limb muscle strength testing; Uni: Unilaterally affected; Bi: Bilaterally affected; R: Right; L: Left; DL: Daily life, GMFCS: Gross Motor Function Classification
System; GMFM: Gross motor function measure.
TABLE 2 | Groups’ characteristics and detected ambulatory activity.
CP TD
Group characteristics
Sample size 15 14
Sex (n and % of girls) 9 (60%) 8 (57%)
Age (year) 12.8 [11.4:14.8] 12.2 [11.5:14.5]
Body mass (kg) 45 [36:53.5] 45.8 [37.8:57.0]
Body height (m) 1.53 [1.40:1.60] 1.57 [1.47:1.67]
Laboratory
Number of steps 38 [28:47] 42.5 [31:46]
Daily life
Number of steps per day1
Week-days 5471 [4665:6930] 7343 [6364:9266]
Weekend days 4059 [3581:5248] 5583 [5086:6394]
Number of consecutive steps per day1
Week-days 287 [136:499] 725 [532:987]
Weekend days 23 [22:25] 22 [21:26]
Maximal number of consecutive steps1
Week-days 377 [154:612] 930 [744:1146]
Weekend days 143 [107:275] 376 [222:553]
Time detected walking per day (min)1
Week-days 54 [24:62] 69 [58:86]
Weekend days 28 [23:32] 45 [38:58]
1: Considering walking bouts with a minimum of 10 steps; value are medians
[IQR] per group. CP: Cerebral palsy; TD: Typical development.
(A, C and F cases). Others (like B, D and E cases) walked
at similar speeds in both environments (CDFs are aligned
or centered). Besides, the difference between the 3 days
of daily life was not homogeneous in all participants. For
instance, the child A had a similar speed distribution
between the 3 days, whereas child B walked slower
during the weekend.
Comparisons Between Laboratory and
Daily Life Speeds
Only the results regarding absolute speed were reported since
normalized speed provided the same results.
Difference Between Walking Speed in Laboratory and
Speed in Daily Life
In the CP group, the median speed in daily life (3 days
assembled) was significantly slower than the median speed in
laboratory [Table 3 and Figure 5 (left)]. This was not the
case for the TD group, for which the median speeds were
similar. Furthermore, no significant difference was found when
the comparison was performed for each subgroup of GMFCS
(Table 3). Figure 6 illustrates the comparison between the
median speed in laboratory and the distribution of daily life
speeds for each participant (individual level). Proportions of
individuals are summarized in Table 4. The main observations
were that none of the children with CP or TD showed a median
in-laboratory speed lower than the first quartile of daily life
speed. Nine out of 14 (64.3%) participants with TD presented a
significantly different [lower (n = 4) or higher (n = 5)] speed in
daily life as compared to the laboratory. In the CP group, the
participants who showed significantly lower speeds in daily life
(n = 7, 46.7%) were equally distributed among the GMFCS levels:
2 with GMFCS I, 3 with GMFCS II and 2 with GMFCS III.
Association Between Speed in Laboratory and Speed
in Daily Life
A significant very good correlation was found between the
median speed in laboratory and in daily life for the CP group
(rho = 0.89, p < 0.001) [Table 3 and Figure 5 (right)]. No
correlation was found for the TD group (rho = 0.22, p < 0.454).
A very good correlation was found for the GMFCS III-subgroup
only (rho = 0.89, p = 0.033).
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FIGURE 4 | Six examples (A–F) of speed distributions (as Cumulative Distribution Function plots) in laboratory (‘Lab’) and 3 days of daily life: 2 week-days (“Day 1,”
“Day 2”), and 1 weekend day. Abbreviations: CP: Cerebral palsy; TD: Typical development; F: Female; M: Male; GMFCS: Gross Motor Function Classification System.
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TABLE 3 | Median speed (m/s) in the CP and TD groups in the two different measurement settings.
Laboratory Daily life Comparisonsw Correlationss Corresponding percentile
Median [IQR] Median [IQR] p-Value ES 95%CI p-Value rho Median [IQR]
CP (n = 15) 1.07 [0.73–1.28] 0.91 [0.58–1.23] 0.015 0.543 [0.02–0.16] <0.001 0.89 60 [50:75]
GMFCS I (n = 6) 1.28 [1.26–1.32] 1.29 [1.21–1.33] 0.313 0.141 [−0.11–0.16] 0.242 0.60 57.5 [51.3–63.8]
GMFCS II (n = 3) 1.07 [0.99–1.19] 0.89 [0.72–1.02] 0.250 0.275 [0.16–0.36] 0.333 1.00 75 [75–85]
GMFCS III (n = 6) 0.69 [0.56–0.73] 0.58 [0.45–0.69] 0.313 0.141 [−0.05–0.26] 0.033 0.89 62.5 [46.3–82.5]
TD (n = 14) 1.29 [1.20–1.40] 1.29 [1.24–1.40] 0.715 0.082 [−0.10–0.10] 0.454 0.22 42.5 [35:68.75]
CP: Cerebral palsy; TD: Typical development; GMFCS: Gross Motor Function Classification System; IQR: Interquartile range; ES: Effect size; 95% CI: Confidence Interval;
rho: Spearman’s correlation coefficient. w: Paired Wilcoxon test; s: Spearman’s rank correlation; Values in bold: significance (p < 0.05).
FIGURE 5 | Comparison (left) and association (right) between median speed in the laboratory and daily life at the group level. ∗ stands for significant difference
(p < 0.05). Abbreviations: LAB: Laboratory; DL: Daily life; CP: Cerebral palsy; TD: Typical development.
FIGURE 6 | Intra-subject comparisons between laboratory and daily life. Daily life speed distribution is represented by the box plots. Stars at the bottom of the box
plots stand for significant difference between distributions, tested by unpaired Wilcoxon tests (∗−: Lab > Daily life; ∗+: Lab < Daily life) for each study participant.
Abbreviations: CP: Cerebral palsy; TD: Typical development; GMFCS: Gross Motor Function Classification System.
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TABLE 4 | Proportion of individuals in the categories comparing speed in laboratory and speed in daily life.
In-lab median speed < [DL
speed range]
In-lab median speed
∈ [DL speed range]
In-lab median speed > [DL
speed range]
In-lab speed significantly
different from DL speed (*)
Proportion of individuals in the group (%)
CP (n = 15) 0.0 66.7 33.3 46.7
TD (n = 14) 0.0 85.7 14.3 64.3
DL: Daily life; In-lab: in-laboratory; CP: Cerebral palsy; TD: Typical development.
Speed in Laboratory Representative of the Speed in
Daily Life
For the CP group, the speed in the laboratory represented the
60th percentile of the speed distribution in daily life (Table 3).
Thus, the majority of children with CP walked at a lower
speed during unsupervised walking. For the TD group, the
corresponding percentile was 42.5, meaning that the speed in
laboratory was between the 40th and the 45th percentiles of the
daily life distribution of speed. Children with TD walked mostly
at a higher speed during unsupervised walking. The median
corresponding percentile for the GMFCS-level subgroups were
57.5, 75, and 62.5 for GMFCS I, II, and III, respectively.
DISCUSSION
The aim of this study was to evaluate the feasibility to compare
in-laboratory and daily-life walking speeds in children with
CP using wearable sensors, in order to gain new insights
regarding the difference between gait capacity and performance
in this population. Walking speed was considered to be a good
indicator of the overall gait function (Middleton et al., 2015) and
knowing its distribution over 3 real-life days revealed feasible
and relevant to highlight the difference between the global level
of performance and capacity. At the group level, children with
CP showed a lower walking speed in daily life as compared
to the laboratory. This was not the case for children with TD.
Nevertheless, at the individual level, children with CP and with
TD showed highly heterogeneous behaviors, and also among the
GMFCS-level subgroups. Furthermore, in contrast to controls, a
high correlation was found between median speeds in laboratory
and daily life for children with CP (for the whole CP group
and the GMFCS III subgroup). The speed adopted by children
with CP during supervised walking corresponded mostly to their
higher speeds in daily life: 60% of their daily walking activity
was at a lower speed than in the laboratory. On the contrary,
the speed adopted by the group of children with TD during
supervised walking corresponded to the lower speeds in daily life:
60% of their daily walking activity was at a higher speed than
in the laboratory.
Considerations at the Group Level
The results found for children with CP, in line with those of our
previous study assessing multiple gait characteristics (Carcreff
et al., 2020) are not in total accordance with previous studies
that used dissimilar metrics to compare gait performance with
gait capacity. The significant slower walking speed in daily
life as compared to the clinical environment was expected. It
can be the result of several, and most probably, combined
reasons. Firstly, the so called ‘Hawthorne effect’ (doing better
when observed) (Berthelot et al., 2011) may have been verified
here: children with CP walked mostly faster during the clinic-
based assessments. Secondly, the external factors present in the
real-life environment may have played an important role in
decreasing gait velocity during daily life measurements. Indeed,
slowing down could reflect the difficulty when dealing with
uneven surfaces and obstacles (Toosizadeh et al., 2015), decreased
concentration (Prajapati et al., 2011; Brodie et al., 2016), and also
fatigue and cognitive-motor interferences which are two major
difficulties associated with CP (Brunton and Rice, 2012; Katz-
Leurer et al., 2014; Carcreff et al., 2019a). However, with our
study participants, we could not draw any conclusion regarding
the effect of fatigue on the walking speed, as illustrated in
Supplementary Figure 1, especially given the few data for later
hours. The high correlation between in-laboratory and daily life
gait speeds was unexpected though. We would have expected
that the wider variety of walking bouts included in the present
analysis would provide different results as compared to our
previous study (Carcreff et al., 2020), hence would better fit the
low to moderate correlations found in the literature (Guinet
and Desailly, 2017; Gosselin et al., 2018; Wittry et al., 2018).
Nonetheless, our results suggested that, for children with CP,
capacity is associated to and exceeds performance (Young et al.,
1996). Considering the results found in each GMFCS level, this
might be especially true for the more affected children (GMFCS
III) even though the small sample size in each subgroup made
difficult to draw definitive conclusion. This is in contrast with
the behavior of healthy controls, and probably higher functioning
children with CP, for whom no correlation and no significant
differences were found. This can be explained by the difference in
speed ranges for children with CP and TD. Indeed, higher range
of speeds in CP favored better correlation. This also meant that
the capacity-performance relation can be in both directions for
TD: underperforming or outperforming their capacity in daily
life. This can be attributed to their ability to vary their pace
depending on the context, i.e., to ‘respond to unpredictability’, as
described by Gosselin et al. (2018). Children with CP have less
motor and attentional reserve for adaptability than their TD peers
(Houwink et al., 2011; Gosselin et al., 2018), which may lead to
quasi-systematic lower performances.
Recent studies which addressed this ‘lab. versus free-
living’ clinical issue in adult and elderly populations agreed
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that clinic-based gait parameters were higher, and actually
corresponded to the highest level of natural walking, i.e., to the
‘best performance’ (Brodie et al., 2016, 2017; Van Ancum et al.,
2019). Even for high functioning people, the time spent walking
at the level (speed or cadence) of in-laboratory walking is rare
(Tudor-Locke et al., 2013). Our findings were not fully aligned
with these statements.
Considerations at the Individual Level
The results described at the group level need to be interpreted
with caution since heterogeneous behaviors were found for
individuals with CP, as well as those with TD, nuancing the
previously mentioned group results. We found that only 46.7% of
children with CP had a significant difference between supervised
and unsupervised walking speed, while at the group level, the
median speeds were highly significantly different. This is likely
due to the small sample size and the high inter-subject variability.
Indeed, the corresponding percentile ranged between 25 and
95, picturing completely different inter-subject behaviors. For
children with TD, 64.3% did not follow the group results and the
corresponding percentile ranged between 25 and 80. These intra-
group heterogeneities are most likely due to dissimilar day-to-
day lifestyles and dissimilar demonstrations of the spontaneous
in-laboratory gait. Indeed, children’s daily activities are very
variable. Depending on the school program, physical activities
highly differ between days. Also, external factors, such as the
weather, were inherently not controlled during the unsupervised
assessments. The protocol should have included more days
of measurement, as suggested by Ishikawa et al. (2013) (a
minimum of 6 days for the higher functioning children, and
4 days for the most affected children), to obtain more stable
measures of habitual ambulatory activity. A compromise had
to be found though, to decrease the risk of patients’ refusing
to wear the sensors in their daily environment, as encountered
for three children of our cohort. Moreover, family situations,
geographic location, and physical activity habits vary significantly
across participants. All these factors could have contributed
to the heterogeneity of the results. They could be further
integrated into a multivariate analysis. In addition, the behaviors
in laboratory may differ among children. First, although we
used modified verbal commands (Nascimento et al., 2012) to
instruct for ‘spontaneous’ speed (“walk as usual, as you were
in the street”), the understanding of the instruction may have
differed. A demonstration or a systematic training phase to let
the participant find his spontaneous speed could have been
considered (Nascimento et al., 2012). Second, the Hawthorne
effect may have resulted in two different outcomes: walking
faster or improving the gait pattern quality to the detriment
of walking speed.
It should be noted that the heterogeneity within the
CP group was not the result of the heterogeneous levels
of impairments, since different results were found for the
same gross motor function (GMFCS and GMFM) levels
(Figure 6). This was in line with previous questionnaire-
based results showing that for the same levels of capacity,
different performances were observed (Holsbeeke et al., 2009).
Accounting for the described individual heterogeneity, this
study brought new evidence, based on objective assessments,
to the relevance of assessing both capacity and performance
for children and youths with CP. Even if the performance
was highly associated with laboratory-based walking, the exact
level of an individual’s performance cannot be predicted
from the laboratory.
Description of the Ambulatory Contexts
The description of the participant’s ambulatory activities showed
big differences between the groups. The number of steps taken by
children with CP and TD was about 5’000 and 7’000, respectively,
during week-days, and 4’000 and 6’000 during weekend days.
This was in agreement with the results of Bjornson et al. which
showed that children with TD take more steps than children
with CP on a daily basis (Bjornson et al., 2007). Furthermore,
this indicates that our study participants did not reach the
recommendations of 10’000 to 15’000 steps per day for children
and adolescents (Tudor-Locke et al., 2011), with the exception of
one child with TD. Several studies have pointed out this issue,
which can be explained by the current tendency of children
and adolescents to be more sedentary because of screen-based
activities (Wu et al., 2017). However, since the focus of the current
study was not to quantify physical activity but rather to qualify
walking performances within meaningful walking bouts, many
short walking bouts (<10 steps) were excluded from the analysis.
In natural walking, most walking bouts are short (Orendurff et al.,
2008) and we most likely overestimated sedentary behaviors by
excluding short bouts.
Clinical Implications
Nowadays almost all lab-based performance measures such as
standardized tests, including 3D gait analysis, serve clinical-
decision making, when real-life outcomes are actually the most
important for the children and their families. The extent to which
gait characteristics measured during 3D gait analysis correlates
with unconstrained daily-life walking is still unknown (Supratak
et al., 2018). It is fundamental to bridge this gap in order to
appreciate the meaningfulness of clinic-based measures for the
patient (Supratak et al., 2018). This study has the merit to
address this issue thanks to walking speed, a clinically meaningful
parameter considered as the sixth vital sign (Fritz and Lusardi,
2009), in opposition to arbitrarily defined levels of physical
activity through ‘activity counts’.
This study emphasized that ecological assessments of gait
should be considered in clinical routine, as a complement to in-
laboratory 3D gait analysis, to obtain realistic information about
motor performance, i.e., to capture an additional construct of
the gait function (Van Ancum et al., 2019). This information
about gait performance is highly valuable for clinicians when
devising a treatment plan that can integrate widely varying
elements from an intensive therapy program (Halma et al.,
2020), through orthotics (Lintanf et al., 2018) to multilevel
lower limb surgery (Amirmudin et al., 2019). Thanks to these
assessments, clinicians will be able to verify that the effect of
a treatment generalizes into the child’s daily life. Alternatives
to the direct assessment of gait performance in daily life
conditions, such as dual-task walking (Katz-Leurer et al., 2014;
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Carcreff et al., 2019a), or walking in semi-standardized or
virtual reality environments (van der Krogt et al., 2014)
can also be considered. Ultimately, the regular integration of
objective day-to-day performance measurements as outcomes
in the long term monitoring of treatments in children with
CP, may allow better adjustment to individual needs and
increase the personalization of motor management. As an
example, with the here presented IMU measurement, the
impact of adaptations of the patient’s environment on his
performance could eventually be monitored and, based on the
results, be adapted.
Feedbacks on the Feasibility of a 3-Days
Real-Life Gait Recordings
Although good acceptability of the measures was reported by
participants and their families overall, daily-life assessments
entail potential pitfalls. Indeed, a number of issues related to
long-term measurements were reported in the diary or identified
after data collection. The participants did not always follow the
instructions to wear an Elastane sleeve or tight pants or socks
to cover the sensors. The sensor fixation (PAL stickies, PAL
Technologies Ltd., United Kingdom) alone was not sufficient.
This problem was reported in 27% of the cases and was generally
fixed by the participants with additional medical tape provided
by the investigator. This should have been recommended from
the beginning, as suggested previously (Del Din et al., 2016c). In
the cases where the sensor fell and was re-placed in a different
orientation (i.e., visible by a change in the signs of the signals),
the PCA calibration was repeated for the corresponding part
of the data. Surprisingly, no issue was reported by the parents
or the caregivers who were in charge of handling the sensors
every evening and morning. Errors were found a posteriori, such
as interruption of the measurement before reaching 10 h of
recording (7h50 in the worst case) most probably due to the
child’s timetable (13.1% of the recordings), and bad switch-off
at the end of the day (3.6% of the recordings). Finally, 9.5%
of the measurements were interrupted because of battery loss
of at least one sensor (after 6h30 of recording in the worst
case). In any case, data was cut at the minimal time shared
between the 4 sensors, resulting in an average of 11 ± 2 h of
analyzed recordings per day. Globally, the feasibility of such
assessments has been confirmed but several improvements need
to be carried out, such as the sensor fixation, to enhance the
usability of IMUs.
Study Limitations
Additional study limitations need to be acknowledged. First, the
sample size was low, only 29 participants, which is why this
pilot study aimed at giving a first methodological framework
to assess daily life performance rather than drawing definitive
clinical conclusions for the CP population. However, the effect
found in the CP group for the comparison between in-
laboratory and daily life median speeds showed a medium
substantial difference (effect size = 0.543) (Sullivan and
Feinn, 2012) which is satisfactory for confidence in these
preliminary results. Besides, limits related to the use of inertial
sensors should be mentioned. Firstly, the calibration method
based on PCA is not the most accurate approach from a
biomechanical point of view. This method was adopted as
an optimal solution since an approach based on functional
calibration (Favre et al., 2009) using a pre-defined set of
movements was difficult to be envisaged for children with
functional disabilities, especially in the home environment
without the supervision of the investigator. The PCA method
is based on the assumption that the pitch angular velocity
is maximal in the sagittal plane during forward walking.
This assumption may have induced potential errors, with
an impact on the computation of shank and thigh angles,
hence on the walking speed estimation (Aminian et al., 2002),
especially for the children with a high level of impairment, with
higher frontal and transverse components at shank and thigh
levels during walking. Further analyses should be undertaken
to find a method for sensor-to-segment alignment that is
accurate and feasible in this challenging population and at
home. This would enable the computation of lower limbs
kinematics, which are highly relevant gait features. Second,
precautionary measures were applied to avoid the inclusion
of non-walking activity into the analysis. However, we cannot
exclude erroneous inclusion of false positives, which can be
responsible for the outliers in the speed distribution (Figure 6).
Furthermore, the double pendulum model proposed by Aminian
et al. (2002) relies on precise leg dimension (thigh and
shank segment lengths) measurements that can be challenging
with patients with bone deformities and joint contractures
(Sabharwal and Kumar, 2008). This was also a potential
source of errors.
Last but not least, while walking speed in laboratory is
estimated under same controlled conditions, walking speed
in real-life condition is affected by the context changing the
locomotion, e.g., due to crowd, weather, or path properties
(Wang and Adamczyk, 2019). Information about this context
of walking in daily life was not available as this is difficult to
obtain in real-world condition unless the use of an additional
system such as GPS (for location, indoor, outdoor) (Wang and
Adamczyk, 2019) or an embedded camera (Hickey et al., 2017).
However, the use of such additional devices is problematic
in our population due to their age and privacy issue. As
an attempt to limit the effect of the context, only walking
bouts longer than 10 steps were included. However, the
power law distribution of walking bouts (Orendurff et al.,
2008), involves much more short walking bouts in daily life
corresponding mostly to indoor walking or walking in a room,
and 10 steps may represent more than the maximum number
of steps taken in a row in the laboratory. Some solutions
could be to include only frequently repeated walking bouts
to eliminate unique behaviors or events from the analysis
(Wang and Adamczyk, 2019); to use technological developments
such as multimodal sensing (e.g., GPS, barometric pressure,
microphone, weather records, etc.) to be more precise regarding
the contexts, e.g., discriminate between indoor and outdoor,
even and irregular surface, or straight and curved path, detect
load carriage, a surrounding crowd or weather conditions
(Wang and Adamczyk, 2019).
Frontiers in Bioengineering and Biotechnology | www.frontiersin.org 12 July 2020 | Volume 8 | Article 812
fbioe-08-00812 July 10, 2020 Time: 18:41 # 13
Carcreff et al. Walking Speed in Cerebral Palsy
CONCLUSION
This pilot study revealed that the assessment of walking speed
in real-life conditions through IMU-based wearable sensors
worn on the shanks and thighs was feasible and relevant
to highlight the differences between a young individual’s
performance and his capacity. Furthermore, results showed that
walking speed was slower during natural walking as compared
to laboratory-based walking in the group of children with CP.
Speeds were also highly correlated which means that these
children tended to under-use their gait capacity during daily
life walking. In contrast, no difference was found between
supervised and unsupervised walking in controls. Nevertheless,
highly heterogeneous behaviors were observed at individual
levels in both groups, and within GMFCS level sub-groups, which
indicated that gait performance cannot be directly estimated from
gait capacity. Overall, this study emphasizes the relevance of
assessing natural walking as a complement to current capacity
evaluations, and gives some clues about how to practically
do it. Both assessments bring different and complementary
information, which are valuable for clinicians, in the process of
treatment planning and follow-up care.
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